2023 - Research.com Microbiology in United Kingdom Leader Award
Paul N. Newton focuses on Malaria, Plasmodium falciparum, Artesunate, Drug resistance and Counterfeit. His Malaria study combines topics in areas such as Internal medicine, Epidemiology and Intensive care medicine. His research in Plasmodium falciparum intersects with topics in Parasite load, Convalescence, Pharmacology and Virology.
His Artesunate research integrates issues from Traditional medicine and Dihydroartemisinin. The Drug resistance study which covers Antibacterial agent that intersects with Melioidosis, Maintenance therapy, Pharmacotherapy, Sulfamethoxazole and Trimethoprim. His Counterfeit research incorporates elements of Chromatography, Raman spectroscopy, Analytical chemistry and Public health.
His primary scientific interests are in Malaria, Internal medicine, Virology, Plasmodium falciparum and Immunology. His Malaria research is multidisciplinary, incorporating elements of Drug resistance, Public health and Environmental health. His work deals with themes such as Gastroenterology, Surgery, Melioidosis and Primaquine, which intersect with Internal medicine.
His Virology study typically links adjacent topics like Immunoglobulin M. Paul N. Newton interconnects Quinine and Chloroquine in the investigation of issues within Plasmodium falciparum. His Artesunate study integrates concerns from other disciplines, such as Counterfeit, Pharmacology and Traditional medicine.
His scientific interests lie mostly in Internal medicine, Environmental health, Malaria, Scrub typhus and Incidence. Paul N. Newton has researched Internal medicine in several fields, including Antibiotics, Antibiotic resistance, Melioidosis and Burkholderia pseudomallei. His is involved in several facets of Malaria study, as is seen by his studies on Primaquine and Plasmodium falciparum.
His Plasmodium falciparum research is mostly focused on the topic Artemisinin. His Scrub typhus research incorporates themes from Evolutionary biology and Immunology. His Virology study frequently links to other fields, such as Drug resistance.
Paul N. Newton mainly focuses on Internal medicine, Malaria, Genotype, Orientia tsutsugamushi and Rickettsia typhi. The concepts of his Malaria study are interwoven with issues in Indel, Incidence and Environmental health. His biological study spans a wide range of topics, including Streptococcus pneumoniae, Veterinary medicine, Antibiotic resistance, Typing and Drug resistance.
His Drug resistance study improves the overall literature in Microbiology. His Orientia tsutsugamushi study is within the categories of Scrub typhus and Virology. His Plasmodium falciparum study combines topics from a wide range of disciplines, such as Genomics, Single-nucleotide polymorphism and Intention-to-treat analysis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley Ea;Dhorda M;Fairhurst Rm;Amaratunga C.
The New England Journal of Medicine (2014)
Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health
Kathryn E. Holt;Heiman Wertheim;Ruth N. Zadoks;Stephen Baker.
Proceedings of the National Academy of Sciences of the United States of America (2015)
Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data
EA Ashley;F Aweeka;KI Barnes;Q Bassat.
BMC Medicine (2015)
Genetic architecture of artemisinin-resistant Plasmodium falciparum.
O Miotto;R Amato;E A Ashley;B MacInnis.
Nature Genetics (2015)
Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2
Arjen M Dondorp;Varunee Desakorn;Wirichada Pongtavornpinyo;Duangjai Sahassananda.
PLOS Medicine (2005)
Counterfeit anti-infective drugs
Paul N Newton;Paul N Newton;Michael D Green;Facundo M Fernández;Nicholas P J Day;Nicholas P J Day;Nicholas P J Day.
Lancet Infectious Diseases (2006)
A Major Genome Region Underlying Artemisinin Resistance in Malaria
Ian H. Cheeseman;Becky A. Miller;Shalini Nair;Standwell Nkhoma.
Science (2012)
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa
Gaurvika M L Nayyar;Joel G Breman;Paul N Newton;Paul N Newton;James Herrington.
Lancet Infectious Diseases (2012)
Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia
Shannon Takala-Harrison;Christopher G. Jacob;Cesar Arze;Michael P. Cummings.
The Journal of Infectious Diseases (2015)
Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance
Sachel Mok;Elizabeth A. Ashley;Elizabeth A. Ashley;Pedro E. Ferreira;Lei Zhu.
Science (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mahidol University
University of Oxford
University of Oxford
Mahidol University
Mahidol Oxford Tropical Medicine Research Unit
MORU Mahidol Oxford Tropical Medicine Research Unit
Georgia Institute of Technology
University of Oxford
University of Oxford
Mahidol University
Universidade Federal de Minas Gerais
Jadavpur University
IBM (United States)
University of Michigan–Ann Arbor
Duke University
Lawrence Berkeley National Laboratory
University of Lausanne
Wageningen University & Research
University of Konstanz
Commonwealth Scientific and Industrial Research Organisation
University of Hawaii at Hilo
Max Planck Society
University of New South Wales
Loyola University Chicago
Australian Centre for Disease Preparedness
University of Florida